SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328700. A total of 47 filers reported holding SUNESIS PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.57 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $1,034,000 | -31.7% | 3,926,468 | +7.5% | 0.00% | -100.0% |
| Q1 2020 | $1,515,000 | +8316.7% | 3,652,153 | +6909.8% | 0.00% | – |
| Q4 2019 | $18,000 | -67.3% | 52,101 | -30.5% | 0.00% | – |
| Q3 2019 | $55,000 | +48.6% | 75,001 | +46.2% | 0.00% | – |
| Q2 2019 | $37,000 | -91.3% | 51,288 | -85.4% | 0.00% | – |
| Q1 2019 | $426,000 | +1675.0% | 350,596 | +503.2% | 0.00% | – |
| Q4 2018 | $24,000 | -44.2% | 58,126 | +172.9% | 0.00% | – |
| Q3 2018 | $43,000 | -61.6% | 21,300 | -59.7% | 0.00% | – |
| Q2 2018 | $112,000 | +229.4% | 52,871 | +326.4% | 0.00% | – |
| Q1 2018 | $34,000 | – | 12,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 7,600,000 | $9,234,000 | 7.03% |
| Samsara BioCapital, LLC | 3,750,000 | $4,556,000 | 3.58% |
| CAXTON CORP | 277,245 | $337,000 | 0.31% |
| BVF INC/IL | 2,287,860 | $2,780,000 | 0.31% |
| Eventide Asset Management | 5,965,455 | $7,248,000 | 0.25% |
| Telemetry Investments, L.L.C. | 197,564 | $240,000 | 0.12% |
| NEA Management Company, LLC | 1,298,274 | $1,584,000 | 0.08% |
| RP Management, LLC | 129,517 | $158,000 | 0.08% |
| Palo Alto Investors LP | 1,162,473 | $1,412,000 | 0.06% |
| Fosun International Ltd | 725,000 | $863,000 | 0.06% |